Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 12, 2026

Aduro Clean Technologies franchit une étape clé avec l’entrée en phase d’exploitation de son usine pilote NGP

View original at globenewswire.com
Aduro Clean Technologies franchit une étape clé avec l’entrée en phase d’exploitation de son usine pilote NGP LONDON, Ontario, 12 févr. 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The FOAK installation site is selected, and the work performed in London will directly guide design and integration while strengthening the Company's readiness for the next phase of scale-up.

    80% confidence

  • The NGP pilot plant is operating according to expectations, and initial campaigns correspond to planned tests.

    80% confidence

  • This milestone reflects rigorous execution by our engineering, operations, and project management teams. With the launch of structured testing operations, the NGP pilot plant becomes a major asset for our commercialization trajectory and stakeholder engagement strengthening.

    80% confidence

  • After commissioning, our priority shifted to operating the integrated system and operational learning. The NGP pilot plant extends the work done with the R2 continuous flow reactor, allowing us to evaluate mixed plastic samples from customer programs and real-world sources under extended, integrated conditions.

    80% confidence

  • These campaigns aim to optimize operating parameters to maximize yields and ensure consistent performance despite feedstock variability, while validating design assumptions for the FOAK industrial facility.

    80% confidence

  • Aduro is well-positioned to generate operational and environmental data supporting advancement of its commercialization program.

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Aduro Clean Technologies franchit une étape clé avec l’entrée en phase d’exploitation de son usine pilote NGP — Source | Via News | ViaNews Market